Addivant Announces Generational Advancement in WESTON® 705 Health and Safety Profile
The results from the most recent toxicology studies, performed in a GLP accredited contract research organization under internationally recognized OECD guidelines, demonstrates no adverse effects at the highest possible concentration levels. Further, in a comparable study, WESTON® 705 is approximately ten times safer than TNPP and three times safer than Tris (2, 4, DTBP) Phosphite, brand names including ALKANOX® 240 and Irgafos® 168.
"This is another important milestone in the commercialization of WESTON® 705, especially at a time when all of us are concerned about the health and safety of the products we are in contact with daily," said John Steitz, Addivant CEO. He added, "We are quite proud of this achievement as many of the largest polymer producers transition to WESTON® 705."
WESTON® 705 is recognized for providing customers with the benefit of superior performance, higher processing productivity and an unprecedented health and safety profile.
Addivant(TM) is an innovator in the field of polymer additives, developing customized solutions that provide customers enhanced application performance, safe handling, and reduction in cost of use. The company is recognized industry-wide for its extensive portfolio of specialty additives including antioxidants, light stabilizers, rubber additives, polymer modifiers, metal deactivators, polymerization inhibitors and intermediates. Addivant is an international company, with 11 plants in five regions as well as research, manufacturing and sales facilities around the globe. Addivant maintains its global headquarters in Connecticut, USA with regional headquarters in: Al Jubail, Saudi Arabia, Basel, Switzerland, and Shanghai, China. Addivant is an independent portfolio company of SK Capital. Visit www.addivant.com for more information.
Addivant(TM), ALKANOX® 240 and WESTON® 705 are trademarks of Addivant.
Tel: +1 203 702 6182
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/53eef9ea-7e67-4b07-b0fc-182decc391f0
Information om Globenewswire
Følg pressemeddelelser fra Globenewswire
Skriv dig op her og modtag pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Globenewswire
Appian Corporation23.5.2018 13:31 | pressemeddelelse
Addiko Bank Implements Digital Banking Solutions on Appian
VITEC23.5.2018 10:01 | pressemeddelelse
VITEC to Showcase High-Quality, Low-Bandwidth Tactical Video Solutions at Eurosatory 2018
Jobindex A/S23.5.2018 08:33 | pressemeddelelse
1. kvartal 2018: Jobindex er kommet godt fra start
Gallene Sciences PVT. LTD22.5.2018 23:02 | pressemeddelelse
MyoGen: Leaders of an Anabolic Revolution
XBiotech, Inc22.5.2018 14:01 | pressemeddelelse
XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis
PubMatic, Inc.22.5.2018 14:01 | pressemeddelelse
Apps Lead the Charge as Mobile Advertising Continues to Grow Worldwide
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum